Drug Class
gene therapy for hemophilia B
Type
brand
Active Ingredient
etranacogene dezaparvovec
📋Overview
Hemgenix is a gene therapy medication designed for individuals with hemophilia B, a rare genetic bleeding disorder caused by a deficiency of clotting factor IX. It works by delivering a functional copy of the gene responsible for producing this clotting factor. Hemgenix is associated with reducing the frequency and severity of bleeding episodes in affected individuals. This therapy represents a significant advancement in the management of inherited bleeding disorders.
📚References
Information from MedlinePlus.gov (NIH).
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
Find Discounts for Hemgenix
Hospitals.net Disclosure
Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.
Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.